BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3593282)

  • 1. Inhibited thrombins. Interactions with fibrinogen and fibrin.
    Kaminski M; McDonagh J
    Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.
    Kaminski M; Siebenlist KR; Mosesson MW
    J Lab Clin Med; 1991 Mar; 117(3):218-25. PubMed ID: 2002278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic affinity chromatography of human thrombin.
    Lundblad RL; Tsai J; Wu HF; Jenzano JW; White GC; Connolly TM
    Arch Biochem Biophys; 1993 Apr; 302(1):109-12. PubMed ID: 8470887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acceleratory effect of thrombin on fibrin clot assembly.
    Mosesson MW; Kaminski M
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):475-8. PubMed ID: 2133225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
    Odake S; Kam CM; Powers JC
    J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the thrombin binding sites on fibrin.
    Meh DA; Siebenlist KR; Mosesson MW
    J Biol Chem; 1996 Sep; 271(38):23121-5. PubMed ID: 8798504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.
    Fenton JW; Olson TA; Zabinski MP; Wilner GD
    Biochemistry; 1988 Sep; 27(18):7106-12. PubMed ID: 3196704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.
    Church FC; Pratt CW; Noyes CM; Kalayanamit T; Sherrill GB; Tobin RB; Meade JB
    J Biol Chem; 1989 Nov; 264(31):18419-25. PubMed ID: 2509458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen.
    Hogg PJ; Jackson CM; Labanowski JK; Bock PE
    J Biol Chem; 1996 Oct; 271(42):26088-95. PubMed ID: 8824251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
    Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
    J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled preparation of thin fibrin films immobilized at solid surfaces.
    Riedel T; Brynda E; Dyr JE; Houska M
    J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U; Schmitz T; Otte M; Dodt J
    Biomed Biochim Acta; 1991; 50(4-6):707-10. PubMed ID: 1801747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal shift assay to probe melting of thrombin, fibrinogen, fibrin monomer, and fibrin: Gly-Pro-Arg-Pro induces a fibrin monomer-like state in fibrinogen.
    Crossen J; Diamond SL
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129805. PubMed ID: 33276061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
    Naski MC; Shafer JA
    J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.